Expression of immune checkpoint molecules and activation markers in T cells from chronic lymphocytic leukemia (CL) patients

被引：0
|
作者：
Palma, M. [1 ,2 ]
Gentilcore, G. [2 ]
Mozaffari, F. [2 ]
Heimersson, K. [2 ]
Nasman-Glaser, B. [2 ]
Hansson, L. [1 ,2 ]
Osterborg, A. [1 ,2 ]
Mellstedt, H. [2 ]
机构：
[1] Karolinska Univ Hosp, Hematol, Stockholm, Sweden
[2] Karolinska Inst, Oncol Pathol, Stockholm, Sweden
来源：
EUROPEAN JOURNAL OF CANCER | 2016年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
21
引用
收藏
页码：S7 / S7
页数：1
相关论文
共 50 条
  • [41] ENDOGLIN MRNA EXPRESSION IS INCREASED IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA WITH POOR PROGNOSTIC MARKERS
    Vrbacky, F.
    Nekvindova, J.
    Vroblova, V.
    Simkovic, M.
    Jiruchova, Z.
    Maly, J.
    Smolej, L.
    HAEMATOLOGICA, 2012, 97 : 518 - 519
  • [42] Enhanced expression of inflammatory cytokines and activation markers in T-cells from patients with chronic heart failure
    Yndestad, A
    Holm, AM
    Müller, F
    Simonsen, S
    Froland, SS
    Gullestad, L
    Aukrust, P
    CARDIOVASCULAR RESEARCH, 2003, 60 (01) : 141 - 146
  • [43] Defining the Immune Checkpoint Landscape in the Bone Marrow and Peripheral Blood of Patients with Chronic Lymphocytic Leukemia (CLL)
    Jain, Nitin
    Basu, Sreyashi
    Thakral, Beenu
    Burger, Jan
    Thompson, Philip A.
    Ferrajoli, Alessandra
    Estrov, Zeev
    Bueso-Ramos, Carlos E.
    Stingo, Francesco
    Bassett, Roland L., Jr.
    Daver, Naval
    Kadia, Tapan M.
    Matthews, Jairo
    Flores, Wilmer
    Somani, Narmeen
    Blando, Jorge
    Kantarjian, Hagop M.
    Allison, James
    Keating, Michael
    Sharma, Padmanee
    Wierda, William G.
    BLOOD, 2016, 128 (22)
  • [44] Fusobacterium nucleatum in colorectal carcinoma and expression of multiple immune checkpoint molecules on T cells
    Kim, Han Sang
    Kim, Wonkyu
    Kim, Chang Gon
    Yoo, Jinseon
    Paik, Soonmyung
    Shin, Eui-Cheol
    Kim, Tae-Min
    Kim, Hoguen
    Ahn, Joong Bae
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
  • [45] Efficacy of Immune Checkpoint Inhibitors in Metastatic Melanoma (MM) Patients with Concurrent Chronic Lymphocytic Leukemia (CLL)
    Guerra, Veronica
    Ologun, Gabriel
    Haydu, Lauren
    Keung, Emily
    Burton, Elizabeth
    Tawbi, Hussein
    Davis, Michael
    Wargo, Jennifer
    Ferrajoli, Alessandra
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S225 - S225
  • [46] SIGNAL REQUIREMENTS FOR ACTIVATION OF LEUKEMIC T-CELLS FROM A CHRONIC LYMPHOCYTIC-LEUKEMIA (T-CLL)
    ZOCCHI, MR
    POGGI, A
    HELTAI, S
    VILLA, A
    INVERARDI, L
    VICARI, A
    SABBADINI, MG
    FERRARINI, M
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1990, 82 (01): : 108 - 113
  • [47] TLR2 Expression on Leukemic B Cells from Patients with Chronic Lymphocytic Leukemia
    Agata Szymańska
    Agnieszka Bojarska-Junak
    Arkadiusz Drobiecki
    Waldemar Tomczak
    Jacek Roliński
    Marek Hus
    Iwona Hus
    Archivum Immunologiae et Therapiae Experimentalis, 2019, 67 : 55 - 65
  • [48] TLR2 Expression on Leukemic B Cells from Patients with Chronic Lymphocytic Leukemia
    Szymanska, Agata
    Bojarska-Junak, Agnieszka
    Drobiecki, Arkadiusz
    Tomczak, Waldemar
    Rolinski, Jacek
    Hus, Marek
    Hus, Iwona
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2019, 67 (01) : 55 - 65
  • [49] Deregulation of the immune system in patients with chronic lymphocytic leukemia
    Skorka, Katarzyna
    Kot, Marlena
    Knap, Joanna
    Giannopoulos, Krzysztof
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2019, 73 : 117 - 132
  • [50] Expression of immune checkpoint molecules in chronic myeloid leukemia at diagnosis and during tyrosine kinase inhibitor therapy
    Dufva, O.
    El Missiry, M.
    Lahteenmaki, H.
    Mustjoki, S.
    ANNALS OF ONCOLOGY, 2015, 26 : 9 - 9
12345